Novo Nordisk Foundation chair calls on industry to respond with urgency to AMR crisis
As part of his intervention at the World Economic Forum in Davos, Lars Rebien Sørensen, chairman of the Novo Nordisk Foundation and Novo Holdings, calls on governments, the biopharma industry and other stakeholders to step up the urgency and respond to the public health crisis in #antimicrobialresistance with new funding models and market incentives.
First published in BioCentury
